Behavioral
Alice Peck Day Memorial Hospital
Alice Peck Day Memorial Hospital was paid $2.09M by Medicaid between Jan 2018 and Dec 2024, across 89 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.
33Billing provider infoALICE PECK DAY MEMORIAL HOSPITAL
LEBANON, NH 03766
LEBANON, NH 03766
33aNPI1003803495assigned 09/30/2005
33bProvider typeMental Health Counselor
28Total paid$2.09M
24GClaims50,459
24DCodes billed89
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Mental Health Counselor providers in New Hampshire
Rank by total paid#5 of 91
Median peer was paid$40K
This provider vs. median52×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,708 | $78K | |
| 2019 | 6,969 | $176K | |
| 2020 | 8,517 | $330K | |
| 2021 | 12,971 | $553K | |
| 2022 | 10,200 | $515K | |
| 2023 | 4,913 | $251K | |
| 2024incomplete | 3,181 | $184K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32% | 12,741 | 9,629 | $674K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 4,704 | 3,599 | $540K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 1,744 | 1,393 | $316K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.7% | 693 | 415 | $118K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.7% | 1,962 | 1,668 | $97K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.8% | 2,826 | 1,639 | $58K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.5% | 1,966 | 1,769 | $31K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 514 | 400 | $29K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,428 | 1,982 | $21K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 172 | 120 | $17K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 231 | 191 | $16K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 216 | 194 | $16K |
77 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,673 | $13K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 268 | $13K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 185 | $12K |
| 80053 | Comprehensive metabolic panel | <1% | 1,959 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 946 | $9K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 106 | $7K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 67 | $6K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 77 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 77 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 589 | $4K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 61 | $4K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 113 | $4K |
| 80061 | Lipid panel | <1% | 427 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,000 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 46 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 595 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 37 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 131 | $3K |
| 90686 | <1% | 959 | $3K | |
| 71045 | Radiologic examination, chest; single view | <1% | 56 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 131 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 75 | $2K |
| 0002A | <1% | 58 | $2K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 13 | $2K |
| 99205 | Prolong outpt/office vis | <1% | 27 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,222 | $2K |
| 0064A | <1% | 65 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 25 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 339 | $1K |
| 0001A | <1% | 33 | $1K | |
| 0004A | <1% | 59 | $1K | |
| 80306 | <1% | 118 | $1K | |
| 0072A | <1% | 55 | $1K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 16 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 18 | $979.65 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 26 | $926.20 |
| 0071A | <1% | 49 | $850.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 243 | $773.58 |
| 87631 | <1% | 16 | $763.58 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 22 | $692.26 |
| 81001 | <1% | 364 | $647.08 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 228 | $585.34 |
| 96127 | <1% | 96 | $550.98 | |
| 86803 | <1% | 39 | $437.47 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 127 | $421.32 |
| 99443 | <1% | 42 | $377.87 | |
| 83690 | <1% | 87 | $354.00 | |
| 84484 | <1% | 50 | $290.90 | |
| 0054A | <1% | 15 | $281.46 | |
| 92015 | Determination of refractive state | <1% | 19 | $237.69 |
| 90656 | <1% | 67 | $213.07 | |
| 87070 | <1% | 30 | $164.48 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 16 | $164.15 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 17 | $141.09 |
| 90480 | <1% | 15 | $131.32 | |
| 87400 | <1% | 26 | $122.78 | |
| 86140 | <1% | 34 | $117.19 | |
| 87077 | <1% | 15 | $90.80 | |
| 85027 | <1% | 44 | $86.14 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 97 | $83.53 |
| 83550 | <1% | 13 | $82.28 | |
| 87081 | <1% | 18 | $61.32 | |
| 83540 | <1% | 13 | $61.06 | |
| 81003 | <1% | 51 | $46.45 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 24 | $41.22 |
| G0008 | Administration of influenza virus vaccine | <1% | 62 | $40.55 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 19 | $34.50 |
| 85652 | <1% | 15 | $27.68 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 17 | $24.97 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 17 | $23.65 |
| 90461 | <1% | 127 | $22.77 | |
| 91300 | <1% | 208 | $0.84 | |
| 91307 | <1% | 149 | $0.60 | |
| 91306 | <1% | 65 | $0.30 | |
| 91305 | <1% | 27 | $0.10 | |
| 90670 | 0% | 13 | $0.00 | |
| 90688 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOONEY, SUSAN (CEO/PRESIDENT)
Parent organizationALICE PECK DAY MEMORIAL HOSPITAL
| Provider | Location | Paid |
|---|---|---|
| Alice Peck Day Memorial Hospital | Lebanon, NH | $179K |
| Alice Peck Day Memorial Hospital | Lebanon, NH | $20K |
| Alice Peck Day Memorial Hospital | Lebanon, NH | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.